FDA Officials Baselessly Claim COVID-19 Vaccines Killed Children: Key Facts
Recently, U.S. Food and Drug Administration (FDA) officials made a controversial claim regarding the safety of COVID-19 vaccines. They alleged that these vaccines resulted in the deaths of at least ten children. However, no supporting evidence has been provided for this assertion.
FDA Claims and Evidence Lacking
Dr. Vinay Prasad, who leads the FDA’s vaccine division, stated in an internal email that “at least 10 children have died after and because of receiving COVID-19 vaccination.” This alarming claim was echoed by FDA Commissioner Dr. Marty Makary during an appearance on Fox and Friends Weekend. Despite the gravity of their statements, neither Prasad nor Makary shared any details or data concerning the alleged deaths.
Responses from Health Authorities
The Department of Health and Human Services, the FDA’s parent agency, did not respond to requests for further information. Furthermore, many health experts emphasize that the benefits of COVID-19 vaccines far outweigh potential risks. This sentiment continues, even after Prasad’s claims.
Understanding COVID-19 Risks in Children
It’s essential to recognize the context of COVID-19 infections among children. Since the pandemic began, over 2,000 children aged 18 and younger in the U.S. have succumbed to COVID-19. Notably, around 700 of these fatalities, approximately 33%, were among infants under one year old.
Myocarditis and Vaccination
- Myocarditis, a rare side effect linked to mRNA COVID-19 vaccines, has garnered attention.
- Research indicates that boys and men aged 12 to 30 are at the highest risk of developing myocarditis post-vaccination.
- Most cases of vaccine-related myocarditis recover fully, according to health experts.
Comparative Risks: Infection vs. Vaccination
Studies illustrate that the risk of developing myocarditis from a COVID-19 infection is significantly higher than from the vaccine. One 2022 analysis found that individuals infected with COVID-19 had a myocarditis risk seven times greater than those vaccinated with an mRNA vaccine.
Conclusion
The discussion about vaccine safety and efficacy continues to be a critical issue. Despite recent claims made by FDA officials, the scientific consensus is clear: the risks posed by COVID-19 infection, especially myocarditis, far exceed those associated with the vaccines. As the dialogue evolves, public trust in vaccines remains paramount.